Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M35.5Revenue $M42.5Net Margin (%)22.5Z-Score2.0
Enterprise Value $M39.5EPS $1.4Operating Margin %25.7F-Score6
P/E(ttm))3.0Cash Flow Per Share $2.2Pre-tax Margin (%)27.4Higher ROA y-yY
Price/Book0.310-y EBITDA Growth Rate %0Quick Ratio2.0Cash flow > EarningsY
Price/Sales0.75-y EBITDA Growth Rate %-7.5Current Ratio2.5Lower Leverage y-yY
Price/Cash Flow0.8y-y EBITDA Growth Rate %18.1ROA % (ttm)7.5Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)9.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M8.7ROI % (ttm)6.1Gross Margin Increase y-yN

Gurus Latest Trades with SKBI

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

SKBI is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SKBI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GREGORY JOHN M10% Owner 2014-12-10Sell0$0view
GREGORY JOHN M10% Owner 2014-12-10Buy103,016$4.56-8.33view

Press Releases about SKBI :

    Quarterly/Annual Reports about SKBI:

    News about SKBI:

    Articles On GuruFocus.com
    Skystar Bio-Pharmaceutical to File Financial Results for Third Quarter of Fiscal 2014 on Friday, Nov Nov 14 2014 
    Skystar Bio-Pharma Featured on Wide World of Stocks Television Nov 05 2014 
    animal vaccination w Oct 11 2011 

    More From Other Websites
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Submission of Matters to a Vote of Security... Dec 05 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Financials Nov 21 2014
    Skystar Bio-Pharmaceutical Reports Third Quarter Fiscal Year 2014 Financial Results Nov 18 2014
    Skystar Bio-Pharmaceutical Reports Third Quarter Fiscal Year 2014 Financial Results Nov 14 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report Nov 14 2014
    Skystar Bio-Pharmaceutical to File Financial Results for Third Quarter of Fiscal 2014 on Friday,... Nov 14 2014
    Skystar Bio-Pharmaceutical to File Financial Results for Third Quarter of Fiscal 2014 on Friday,... Nov 14 2014
    Skystar Bio-Pharma Featured on Wide World of Stocks Television Nov 05 2014
    Skystar Bio-Pharma Featured on Wide World of Stocks Television Nov 05 2014
    Skystar Bio-Pharmaceutical (SKBI) Upgraded From Hold to Buy Sep 09 2014
    Skystar to Launch Probiotic Supplement for Dairy Cows by End of Fiscal 2014 Aug 26 2014
    Skystar Bio-Pharmaceutical Reports Second Quarter Fiscal Year 2014 Financial Results Aug 14 2014
    Skystar Bio-Pharmaceutical to File Financial Results for Second Quarter of Fiscal 2014 on Thursday,... Aug 14 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 10-Q, Quarterly Report Aug 14 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Material Modification to Rights of Security... Jul 21 2014
    SKYSTAR BIO-PHARMACEUTICAL CO Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 16 2014
    Skystar Bio-Pharmaceutical Announces $5 Million Registered Direct Offering Jul 16 2014
    Skystar Bio-Pharma launches bovine immunoglobulin G kits in China Jul 08 2014
    Skystar Launches Bovine Immunoglobulin G (IgG) Kits in China Jul 08 2014
    Skystar Bio-Pharmaceutical's (SKBI) CEO Weibing Lu on Q1 2014 Results - Earnings Call Transcript May 16 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK